Skip to main content
KYNB logo

KYNB · Kyntra Bio, Inc. · Analyst Estimates

Track KYNB — free
$4.63 +0.13 (+2.89%) Q2 2026 earnings call transcript
Market Cap
$18.22M
Shares
4.05M
Volume · Oct 28 8033 Avg daily vol (3M) 20.82K

Analyst Estimates

Compare analyst forecasts for Kyntra Bio, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-14 21:31 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-12.41
-12.41
-12.41
1
-13.75
-13.75
-13.89
-13.89
1
1
0
0
Revenue
USD
Publication date not stated
4.80M
6.42M
8.90M
5
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-16.45
-14.23
-12.01
2
-14.23
-11.44
-9.73
-9.73
2
2
0
0
Revenue
USD
Publication date not stated
5.00M
7.33M
13.00M
5
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-3.75
-3.34
-2.92
2
-3.34
-3.33
-3.39
-3.39
2
2
0
0
Revenue
USD
Publication date not stated
1.00M
1.72M
3.40M
5
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-4.04
-3.47
-2.89
2
-3.47
-3.50
-3.51
-3.51
2
2
0
0
Revenue
USD
Publication date not stated
1.00M
2.32M
3.31M
5
— — — — — — — —
Key facts CIK 921299 CUSIP 31572Q881 13F (30d) 4 filings 4 filers Visit website Investor relations